“`html
On September 15, 2025, Rothschild & Co initiated coverage of West Pharmaceutical Services (NYSE:WST) with a Buy recommendation. The average one-year price target for West Pharmaceutical Services is $320.57 per share, representing a potential upside of 24.48% from its latest closing price of $257.54.
The projected annual revenue for West Pharmaceutical Services is $3,191 million, indicating a 7.80% increase. Institutional ownership has decreased by 0.51% over the last three months, with total shares owned dropping to 89,117K. The company’s put/call ratio stands at 0.57, reflecting a bullish market sentiment.
“`
